Form 4: Northrop Grumman CEO's Routine Stock Transactions

Northrop Grumman CEO Kathy J. Warden reported the vesting of restricted stock rights and subsequent tax-related share disposition.

Summary

• Kathy J. Warden, Chair, CEO, and President of Northrop Grumman Corp, reported transactions involving the company's common stock and restricted stock rights (RSRs).
• On February 17, 2026, 10,760 Restricted Stock Rights (RSRs) granted under the 2011 Long-Term Incentive Stock Plan (LTISP) on February 16, 2023, vested.
• Upon vesting, 10,760 shares of common stock were acquired at a price of $0.
• Concurrently, 4,857 shares of common stock were disposed of at a price of $701.12, likely to cover tax liabilities associated with the RSR vesting.
• Following these transactions, Kathy J. Warden beneficially owns 196,680.56 shares of common stock.
• Additionally, 31,020 derivative securities (RSRs) are beneficially owned, which include future vesting RSRs from 2024, 2025, and 2026 grants.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive event for the executive, reflecting the successful vesting of long-term incentives, which is a routine and expected part of executive compensation. It has a neutral impact on the company's operational outlook.

Positives

• The vesting of 10,760 Restricted Stock Rights demonstrates the payout of long-term incentive compensation to the CEO, aligning management's interests with shareholder value over time.
• The acquisition of common stock at a $0 price reflects the successful realization of equity-based compensation.

Negatives

• A disposition of 4,857 shares of common stock occurred, likely for tax withholding purposes, which slightly reduces the direct beneficial ownership of the CEO.

Future Outlook

The filing indicates future vesting events for Restricted Stock Rights: 11,155 RSRs will vest on February 16, 2027; 11,752 RSRs will vest on February 18, 2028; and 8,113 RSRs will vest on February 12, 2029.

Industry Context

StockSavvy.ai notes that Form 4 filings detailing executive compensation, such as the vesting of restricted stock and subsequent tax-related share sales, are routine disclosures in the defense and aerospace industry, reflecting standard long-term incentive plans designed to align executive interests with shareholder returns.

Comparison to Industry Standards

• This filing primarily details an executive's personal stock transactions related to compensation, rather than company-wide operational or financial results. Therefore, it does not provide sufficient information to make a direct comparison of company performance against global benchmarks or specific comparable projects and results.
• However, the use of Restricted Stock Rights (RSRs) as a component of executive compensation is a common practice across major corporations, including peers in the defense sector like Lockheed Martin (LMT) or Raytheon Technologies (RTX), reflecting a standard approach to long-term incentive alignment.

Stakeholder Impact

• Shareholders: The filing reflects routine executive compensation, which is a standard cost of doing business and aligns executive interests with long-term company performance. No direct material impact on current share value is implied by this routine transaction.
• Employees: No direct impact on general employees is indicated by this executive-specific compensation event.
• Management: The CEO's compensation structure, including RSRs, continues to incentivize long-term performance and retention.

Next Steps

• Future vesting of 11,155 RSRs on February 16, 2027.
• Future vesting of 11,752 RSRs on February 18, 2028.
• Future vesting of 8,113 RSRs on February 12, 2029.

Key Dates

Recommendation

This Form 4 filing details a routine executive compensation event involving the vesting of restricted stock and a subsequent tax-related share disposition. Such transactions are pre-scheduled and expected, providing no new material information that would alter the fundamental investment thesis for Northrop Grumman. Therefore, a 'hold' recommendation is appropriate, as the filing does not present a catalyst for a significant change in stock valuation or investment strategy.

Keywords

Northrop Grumman, NOC, Form 4, Insider Transaction, Restricted Stock Rights, Stock Vesting, Executive Compensation, Kathy Warden